Acidic and Basic Fibroblast Growth Factors have Comparable Effects on the Haemostatic Function of Vascular Endothelium

References

• Baird A., Ling N. Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: Implications for a role of heparinase-like enzymes in the neovascular response. Biochem. Biophys. Res. Commun. 1987; 142: 428–435
   PubMed Web of Science ®Google Scholar
• Baird A., Klagsbrun M. The fibroblast growth factor family. Cancer Cells 1991; 3: 239–243
   PubMed Web of Science ®Google Scholar
• Baird A., Schubert D., Ling N., Guillemin R. Receptor-and heparin-binding domains of basic fibroblast growth factor. Proc. Natl Acad. Sci. USA 1988; 85: 2324–2328
   PubMed Web of Science ®Google Scholar
• Bikifalvi A., Dupuy E., Inyang A. L., Fayein N., Leseche G., Courtois Y., Tobelem G. Binding, internalisation and degradation of basic fibroblast growth factor in human microvascular endothelial cells. Exp. Cell. Res. 1989; 181: 75–84
   Google Scholar
• Burgess W. H., Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 1989; 58: 575–606
   PubMed Web of Science ®Google Scholar
• Canfield A. E., Boot-Handford R., Schor A. M. Thrombospondin gene expression by endothelial cells in culture is modulated by cell proliferation, cell shape and subtratum. Biochem. J. 1990; 268: 225–230
   Google Scholar
• Chesterman C. N., Owe-Young R., Macpherson J., Krilis S. A. Substrate for endothelial prostacyclin production in the presence of platelets exposed to collagen is derived from the platelets rather than the endothelium. Blood 1986; 67: 1744–1750
   Google Scholar
• Dawes J., Clemetson K. J., Gogstad G. D., McGregor J., Clezardin P., Prowse C. V., Pepper D. S. A radioimmunoassay for thrombospondin, used in a comparative study of thrombospondin, β-thromboglobulin and platelet factor 4 in healthy volunteers. Thromb. Res. 1983; 29: 569–581
   PubMed Web of Science ®Google Scholar
• Donoviel D. B., Amacher S. L., Judge K. W., Bornstein P. Thrombospondin gene expression is associated with mitogenesis in 3T3 cells: induction by basic fibroblast growth factor. J. Cell. Physiol. 1990; 145: 16–23
   Google Scholar
• Flaumenhaft R., Abe M., Mignatti P., Rifkin D. B. Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells: Regulation of plasminogen activator activity. J. Cell Biol. 1992; 118: 901–909
   PubMed Web of Science ®Google Scholar
• Gospodarowicz D., Cheng J. Heparin protects basic and acidic FGF from inactivation. J. Cell. Physiol. 1986; 128: 475–484
   PubMed Web of Science ®Google Scholar
• Gospodarowicz D., Ferrara N., Schweigerer L., Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocrine Rev. 1987; 8: 95–114
   PubMed Web of Science ®Google Scholar
• Gospodarowicz D., Mescher A. L., Birdwell C. R. Control of cellular proliferation by the fibroblast and epidermal growth factors. Natl. Cancer. Inst. Monogr. 1978; 48: 109–130
   Google Scholar
• Gospodarowicz D., Neufeld G., Schweigerer L. Molecular and biological characterization of fibroblast growth factor: An angiogenic factor which also controls the proliferation and differentiation of mesoderm and neuroectodermal derived cells. Cell. Differ. 1986; 19: 1–17
   PubMedGoogle Scholar
• Hasegawa N., Yamamoto M., Yamamoto K. Stimulation of cell growth and inhibition of prostacyclin production by heparin in human umbilical vein endothelial cells. J. Cell. Physiol. 1988; 37: 603–607
   Google Scholar
• Hogg P. J., Stenflo J., Mosher D. F. Thrombospondin is a slow tight-binding inhibitor of plasmin. Biochem. 1992; 31: 265–269
   Google Scholar
• Inyang A. L., Bikiflavi A., Lu H., Tobelem G. Chloroquine's modulation of endothelial cell activity induced with basic fibroblast growth factor and human serum: Effect on mitogenesis, protease production and cell migration. Cell Biol. Int. Reports 1990; 4: 35–46
   Google Scholar
• Isacchi A., Statuto M., Chiesa R., Bergonzoni L., Rusnati M., Sarmientos P., Ragnotti G., Presta M. A 6-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. Proc. Natl Acad. Sci. USA 1991; 88: 2628–2632
   PubMed Web of Science ®Google Scholar
• Ishihara M., Tyrrell D. J., Stauber G. B., Brown S., Cousens L. S., Stack R. J. Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor. J. Biol. Chem. 1993; 268: 4675–4683
   PubMed Web of Science ®Google Scholar
• Konkle B. A., Ginsburg D. The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression. J. Clin. Invest. 1988; 82: 579–585
   Google Scholar
• Lyons-Giordano B., Brinker J. M., Kefalides N. A. The effect of heparin on fibronectin and thrombospondin synthesis and mRNA levels in cultured human endothelial cells. Exp. Cell Res. 1990; 86: 39–46
   Google Scholar
• Maciag T., Cerundolo J., Ilsley S., Kelley P. R., Forand R. An endothelial cell growth factor from bovine hypothalamus. Identification and partial characterisation. Proc. Natl Acad. Sci. USA 1979; 76: 5674–5678
   PubMed Web of Science ®Google Scholar
• Minter A. J., Dawes J., Chesterman C. N. Effects of heparin and endothelial cell growth supplement on haemostatic functions of vascular endothelium. Thromb. Haemostas. 1992; 67: 718–723
   Google Scholar
• Montesano R., Vassalli J. D., Baird A., Guilleman R., Orcu L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl Acad. Sci. USA 1986; 83: 7297–7301
   PubMed Web of Science ®Google Scholar
• Moscatelli D. Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfate but slowly from receptors. J. Biol. Chem. 1992; 267: 25803–9
   PubMedGoogle Scholar
• Moscatelli D., Presta M., Rifkin D. B. Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis and migration. Proc. Natl Acad. Sci. USA 1986; 83: 2091–2095
   PubMed Web of Science ®Google Scholar
• Muller S. N., Thomas K. A., DiSalvo J., Levine E. M. Stabilisation by heparin of acidic fibroblast growth factor mitogenicity for human endothelial cells in vitro. J. Cell. Physiol. 1989; 140: 439–448
   Google Scholar
• Mumby S. M., Abbott-Brown D., Raugi G., Bornstein P. Regulation of thrombospondin secretion by cells in culture. J. Cell. Physiol. 1984; 20: 280–288
   Google Scholar
• Neufeld G., Gospodarowicz D. The identification and partial characterization of fibroblast growth factor receptor of baby hamster kidney cells. J. Biol. Chem. 1985; 260: 13860–13868
   PubMed Web of Science ®Google Scholar
• Neufeld G., Gospodarowicz D. Basic and acidic fibroblast growth factor interact with the same cell surface receptors. J. Biol. Chem. 1986; 261: 5631–5637
   PubMed Web of Science ®Google Scholar
• Odekon L. E., Sato Y., Rifkin D. B. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J. Cell. Physiol. 1992; 150: 258–263
   PubMed Web of Science ®Google Scholar
• Pepper M. S., Belin D., Montesano R., Orci L., Vassalli J.-D. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J. Cell Biol. 1990; 111: 743–755
   PubMed Web of Science ®Google Scholar
• Pepper M. S., Ferrara N., Orci L., Montesano R. Vascular endothelial cell growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun. 1991; 181: 902–906
   PubMed Web of Science ®Google Scholar
• Pepper M. S., Sappino A. P., Montesano R., Orci L., Vassalli J.-D. Plasminogen activator inhibitor-1 is induced in migrating endothelial cells. J. Cell. Physiol. 1992; 153: 129–139
   Google Scholar
• Presta M., Maier J. A. M., Rusnati M., Ragnotti G. Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. J. Cell. Physiol. 1989; 140: 68–74
   PubMed Web of Science ®Google Scholar
• Rifkin D. B., Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol. 1989; 109: 1–6
   PubMed Web of Science ®Google Scholar
• Rifkin D. B., Quarto N., Mignatti P., Bizik J., Moscatelli D. New observations on the intracellular localization and release of bFGF. Ann. NY Acad. Sci. 1991; 638: 204–206
   Google Scholar
• Ristimaki A., Ylikorkala O., Viinikka L. Effect of growth factors on human vascular endothelial cell prostacyclin production. Arteriosclerosis 1987; 10: 653–657
   Google Scholar
• Roghani M., Moscatelli D. Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J. Biol. Chem. 1992; 267: 22156–22162
   PubMed Web of Science ®Google Scholar
• Rusnati M., Urbinati C., Presta M. Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: Role of the low affinity heparin-like bFGF receptors. J. Cell. Physiol. 1993; 154: 152–161
   PubMed Web of Science ®Google Scholar
• Saksela O., Rifkin D. B. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J. Cell Biol 1990; 110: 767–775
   PubMed Web of Science ®Google Scholar
• Schreiber A. B., Kenny J., Kowalski W. J., Friesel R., Mehlman T., Maciag T. Interaction of endothelial cell growth factor with heparin: Characterisation by receptor and antibody recognition. Proc. Natl Acad. Sci. USA 1985; 82: 6138–6142
   PubMed Web of Science ®Google Scholar
• Schweigerer L., Neufeld G., Mergia A., Abraham J. A., Fiddes C, Gospodarowicz D. Basic fibroblast growth factor in human rhabdomyosarcoma cells: Implications for the proliferation and neovascularization of myoblast derived tumors. Proc. Natl Acad. Sci. USA 1987; 84: 842–846
   PubMedGoogle Scholar
• Tan E. M., Rouda S., Greenbaum S. S., Moore J. H., Jr, Fox J. W. Acidic and basic fibroblast growth factors down-regulate collagen gene expression in keloid fibroblasts. Am. J. Pathol. 1993; 142: 463–470
   PubMed Web of Science ®Google Scholar
• Tannenbaum S. H., Chao E. S., Gralnick H. R. Heparin enhances endothelial cell von Willebrand factor content by growth factor dependent mechanisms. Thromb. Haemostas. 1994; 71: 770–776
   Google Scholar
• Thomas K. A., Gimenez-Gallego G. Fibroblast growth factors: Broad spectrum mitogens with potent angiogenic activity. Trends in Biochemical Science 1986; 11: 81–84
   Google Scholar
• Vlodavsky I., Bashkin P., Ishai-Michaeli R., Chajek-Shaul T., Bar-Shavit R., Haimovitz-Friedman A., Klagsbrun M., Fuks Z. Sequestration and release of basic fibroblast growth factor. Ann. NY Acad. Sci. 1991; 638: 207–220
   Google Scholar
• Vlodavsky I., Folkman J., Sullivan K., Fridman R., Ishai-Michaeli R., Sasse J., Klagsbrun M. Endothelial cell derived basic fibroblast growth factor: Synthesis and deposition into subendothelial extracellular matrix. Proc. Natl Acad. Sci. USA 1987; 84: 2292–2296
   PubMed Web of Science ®Google Scholar
• Weksler B. B. Heparin and acidic fibroblast growth factor interact to decrease prostacyclin synthesis in human endothelial cells by affecting both prostaglandin H synthase and prostacyclin synthase. J. Cell. Physiol. 1990; 142: 514–522
   PubMedGoogle Scholar